Anti-depressants and centrally active agents for fibromyalgia syndrome

The objective is to assess the efficacy and safety of anti-depressants and centrally active agents in the treatment of fibromyalgia syndrome.

This is a protocol.

Health topics:

Neurology > Fibromyalgia

Rheumatology > Fibromyalgia

Published:

18 April 2012

Authors:

Nishishinya MB, Walitt B, Urrútia G, Mease PJ, Rodríguez A, Riera Lizardo RJ, González LE, Darko G

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Nishishinya MB, Walitt B, Urrútia G, Mease PJ, Rodríguez A, Riera Lizardo RJ, González LE, Darko G. Anti-depressants and centrally active agents for fibromyalgia syndrome. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006192. DOI: 10.1002/14651858.CD006192